Medica Venture Partners

Medica Venture Partners is a globally operating healthcare and life sciences venture capital fund investing in Israel, Europe, and the United States. The firm provides equity financing, management assistance, and expertise to early-stage startups and seed-stage companies across various sectors, including medical devices, pharmaceuticals, biotechnology, and genomics. Medica co-invests with leading healthcare funds worldwide and has a unique operational base in Israel.

The firm's investment strategy encompasses a wide range of stages, from seed to late-stage investments, including Series A, B, and C rounds, as well as growth, late-stage, pre-IPO, buyout, turnaround, and distressed situations. Medica's geographical focus spans Israel, the United States, and Europe, with a particular emphasis on healthcare, biotechnology, pharmaceuticals, medical devices, and genomics industries.

Medica Venture Partners has a track record of supporting companies developing breakthrough products, such as first and second-generation percutaneous heart valves and desktop computed radiography. The firm has made 39 investments and achieved 10 exits, demonstrating its commitment to fostering innovation in the healthcare sector.